Latest Revenue Generation News

Imricor Medical Systems has welcomed Oklahoma Heart Institute as the fourth U.S. site in its pivotal VISABL-AFL clinical trial, accelerating patient recruitment and the FDA approval pathway for its MRI-guided cardiac ablation technology.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

1414 Degrees has made significant strides in developing its Aurora Energy Precinct, securing crucial regulatory approvals for its battery storage system and progressing its battery materials and hydrogen technologies.

Helios Energy has marked a key milestone with its first oil and condensate sales from the Presidio Oil Project in Texas, signaling a shift from exploration to early-stage production. The company is now focused on securing funding for further development and drilling activities.

Macro Metals Limited has advanced its strategic position by securing export access at Utah Point and acquiring a 27.3% stake in the Extension Iron Ore project, setting the stage for growth in FY26.

Papyrus Australia has taken a significant step towards commercialisation with a $4.2 million supply contract and the near completion of its Adelaide Rapid Prototyping and R&D Facility.

EVE Health Group has completed manufacturing and distribution setup for Libbo™, its innovative oral dissolving film for erectile dysfunction, paving the way for near-term patient access via telehealth and pharmacy channels.

Fluence Corporation Limited reported a positive net operating cash flow of US$3.824 million for the December 2025 quarter, ending with a strong cash position of US$16.64 million. The company’s disciplined spending and financing activities underpin its stable liquidity outlook.

Blue Star Helium has achieved its first commercial helium production at the Galactica Project in Colorado, marking a pivotal step as it ramps up operations and secures funding for expansion in 2026.

Volt Resources has made significant strides in its US graphite refinery project and secured major funding for its Bunyu Graphite Mine in Tanzania, positioning itself strongly in the critical minerals sector.

Imricor Medical Systems has achieved multiple world-first procedures using real-time MRI guidance for cardiac ablation, advancing clinical trials and regulatory progress amid a strategic commercial expansion.

Emyria Limited has reported strong quarterly revenue growth driven by the expansion of its Empax clinic network across multiple Australian states, supported by a recent $8 million institutional placement to fund its national rollout and workforce expansion.